The world's first maximum-security lab connected to a synchrotron light source
In Campinas, Brazil has taken a quiet but consequential step in the long human effort to see matter as it truly is — and to turn that vision into medicine, technology, and sovereignty. President Lula inaugurated four new research lines at Sirius, Latin America's most advanced particle accelerator, backed by R$ 2.8 billion in cumulative public investment. The expansion is not merely a scientific milestone; it is a wager that a nation's capacity to examine the atomic world can determine its place in the industrial one. Where electrons are made to dance, it seems, futures are also being written.
- Brazil's dependence on foreign microchips and pharmaceutical ingredients has long exposed a structural vulnerability — Sirius now exists to close that gap from the atomic level up.
- Four new research lines named after native wildlife — Tatu, Sapucaia, Quati, and Sapê — came online simultaneously, each targeting a different frontier of materials science, from soil composition to superconductors.
- The Sapê line carries the highest strategic weight, designed specifically to support domestic semiconductor research and the ambition of a Brazilian microchip industry.
- An unprecedented engineering feat is underway next door: Projeto Orion will become the world's first maximum-containment biosafety laboratory physically connected to a synchrotron, requiring vibration-dampening technology invented for this project alone.
- The inauguration doubled as the launch of a national health innovation program, signaling that discoveries made at Sirius are expected to move directly into vaccines and medicines — not remain in academic journals.
- With research capacity set to double and proposals open to both domestic and international scientists, Brazil is positioning Sirius not as a closed national asset but as a global instrument anchored in Brazilian soil.
On a Monday in Campinas, President Lula cut the ribbon on four new research lines at Sirius — the most sophisticated scientific machine Brazil has ever built. The expansion, funded by R$ 800 million through the Novo PAC program, brings total public investment in the fourth-generation synchrotron to R$ 2.8 billion, the largest commitment to scientific infrastructure in the country's history.
The four lines — named Tatu, Sapucaia, Quati, and Sapê after Brazilian wildlife — each function as an independent station where brilliant radiation produced by accelerated electrons allows researchers to examine materials at the nanometer scale. The Sapê line carries the greatest strategic weight, focused on semiconductors and superconductors to directly support Brazil's domestic microchip ambitions. The others will probe soil composition, metal alloys, and complex proteins under extreme conditions, collapsing the distance between laboratory discovery and industrial application.
The ceremony also served as a tour of the adjacent Projeto Orion construction site — a biosafety facility operating at the NB4 maximum-containment level, budgeted at R$ 1.4 billion. When complete, it will be the world's first high-security biological laboratory physically connected to a synchrotron light source, a feat that required inventing vibration-dampening technology that had never existed before. Domestic supply chain participation reached 85 percent of total construction costs — a deliberate measure of how much of the work remained within Brazil.
The inauguration also launched the National Program for Radical Innovation in Health, a government initiative to channel Sirius discoveries directly into the public health system. Reducing dependence on foreign active pharmaceutical ingredients is an immediate priority, with the new lines expected to accelerate drug and vaccine testing timelines. Research capacity at the facility is set to double, with proposals reviewed by peers and offered free to Brazilian and international scientists alike — opening a world-class instrument to the global community while keeping its roots firmly in Brazilian ground.
President Luiz Inácio Lula da Silva stood in Campinas on Monday to cut the ribbon on four new research lines at Sirius, the most advanced scientific machine Brazil has ever built. The particle accelerator, housed at the National Center for Energy and Materials Research, had just received R$ 800 million in federal funding—money that brings the total public investment in this fourth-generation synchrotron to R$ 2.8 billion. The expansion represents the largest single commitment to scientific infrastructure in the country's history.
The four new lines carry names drawn from Brazilian wildlife: Tatu, Sapucaia, Quati, and Sapê. Each functions as an independent station for capturing brilliant radiation produced by accelerated electrons, allowing researchers to examine materials at the nanometer scale. The Sapê line will focus on the most demanding work—studying superconductors and semiconductors with the precision needed to support Brazil's domestic microchip industry. The other three lines will work in concert, observing how soil composition, strategic metal alloys, and complex proteins behave under extreme pressure and temperature. This capability matters because it collapses the time between discovery and industrial application.
The funding came through the Novo PAC, the government's growth acceleration program, coordinated by the Ministry of Science, Technology and Innovation. The ceremony drew the CNPEM's scientific committee, cabinet ministers from strategic portfolios, and regional authority heads. After the formal unveiling of the new lines, the presidential delegation toured the adjacent construction site of Projeto Orion, a biosafety facility that will operate at the highest containment level—NB4—and cost R$ 1.4 billion to complete.
Orion represents something unprecedented: the world's first maximum-security biological laboratory physically connected to a synchrotron light source. The engineering challenge was substantial. Connecting the two required developing vibration dampers that had never been built before, technology that had to be invented specifically for this project. The effort pushed the domestic supply chain participation to 85 percent of the total construction cost—a measure of how much of the work stayed within Brazil rather than flowing to foreign contractors.
The inauguration also served as the launching point for the National Program for Radical Innovation in Health, a government initiative designed to move discoveries made at Sirius directly into the public health system. The Health Ministry made clear that reducing Brazil's dependence on foreign active pharmaceutical ingredients is an immediate priority. By using the new synchrotron lines to accelerate drug and vaccine testing, the government hopes to compress the timeline for bringing high-technology medicines to market. With these new facilities operational, Sirius's capacity to absorb graduate research and private corporate projects is expected to double. Proposals will be reviewed by peers and offered free to both Brazilian and international scientists, opening the facility to the global research community while anchoring advanced science in Brazilian soil.
Notable Quotes
The new lines will provide direct support to Brazil's semiconductor industry and domestic microchip development— CNPEM technical reports
The government's immediate priority is reducing domestic dependence on foreign active pharmaceutical ingredients— Health Ministry representatives
The Hearth Conversation Another angle on the story
Why does a particle accelerator matter to a country's health system? They seem like completely separate worlds.
They're not separate at all. When you can see how molecules behave at the atomic level, you can design drugs more precisely. Instead of trial and error, you're working from actual knowledge. That speeds everything up—and it keeps the money and expertise inside the country instead of buying it from abroad.
So this is about independence, not just science?
It's both. Brazil has been paying foreign companies for active ingredients in medicines for decades. Now they're building the tools to make those ingredients themselves. The synchrotron is the tool that makes that possible.
What's unusual about connecting a biosafety lab to a particle accelerator?
Nobody's done it before. A biosafety lab needs to be completely sealed and isolated. A synchrotron produces radiation that needs to travel through the air. Getting those two things to work together required inventing new technology just to make the connection work.
And the domestic supply chain number—85 percent—why does that matter?
It means the money stays in Brazil. It means Brazilian companies are building the equipment, training workers, developing expertise. It's not just about the science. It's about building an economy around that science.
What happens next?
Orion finishes construction by the end of the year. Then researchers start using both facilities together. The capacity doubles. More scientists can work here. More discoveries happen. More medicines get developed faster.